ANAPTYSBIO INC. - COMMON STOCK
26.34
02-مايو-24 15:59:54
15 متأخرة بدقائق
الأسهم
+0.32
+1.23%
نطاق اليوم
24.75 - 26.74
ISIN
N/A
المصدر
NASDAQ
-
AnaptysBio to Participate at the Cowen and Company 43rd Annual Health Care Conference
27 فبراير 2023 16:05:01 بحسب Nasdaq GlobeNewswire
-
AnaptysBio Announces Stock Repurchase Plan
13 يناير 2023 09:00:00 بحسب Nasdaq GlobeNewswire
-
AnaptysBio Announces Portfolio Update Across Best-in-Class Immune Cell Modulating Antibodies
05 يناير 2023 16:05:00 بحسب Nasdaq GlobeNewswire
-
02 ديسمبر 2022 09:00:00 بحسب Nasdaq GlobeNewswire
-
AnaptysBio to Participate at the Piper Sandler 34th Annual Healthcare Conference
21 نوفمبر 2022 13:56:39 بحسب Nasdaq GlobeNewswire
-
AnaptysBio to Participate in Upcoming November Investor Conferences
09 نوفمبر 2022 14:10:17 بحسب Nasdaq GlobeNewswire
-
AnaptysBio Announces Third Quarter 2022 Financial Results and Provides Pipeline Update
08 نوفمبر 2022 16:05:01 بحسب Nasdaq GlobeNewswire
-
05 أكتوبر 2022 09:00:00 بحسب Nasdaq GlobeNewswire
-
AnaptysBio Announces Sale of Zejula Royalties for Up To $45 Million
12 سبتمبر 2022 07:30:00 بحسب Nasdaq GlobeNewswire
-
31 أغسطس 2022 16:15:00 بحسب Nasdaq GlobeNewswire
-
AnaptysBio Announces Second Quarter 2022 Financial Results and Provides Pipeline Update
08 أغسطس 2022 16:05:03 بحسب Nasdaq GlobeNewswire
-
AnaptysBio to Participate at the 2022 Wedbush PacGrow Healthcare Virtual Conference
05 أغسطس 2022 16:00:00 بحسب Nasdaq GlobeNewswire
-
AnaptysBio to Participate at the 2022 Jefferies Healthcare Conference
02 يونيو 2022 16:05:01 بحسب Nasdaq GlobeNewswire
-
AnaptysBio Announces First Quarter 2022 Financial Results and Provides Pipeline Update
04 مايو 2022 16:15:01 بحسب Nasdaq GlobeNewswire
-
27 أبريل 2022 16:15:00 بحسب Nasdaq GlobeNewswire
-
AnaptysBio Appoints Daniel Faga As Interim Chief Executive Officer
21 مارس 2022 16:15:00 بحسب Nasdaq GlobeNewswire
-
AnaptysBio Reports Imsidolimab ACORN Phase 2 Clinical Trial Data in Moderate-to-Severe Acne
14 مارس 2022 16:20:00 بحسب Nasdaq GlobeNewswire
-
07 مارس 2022 08:50:00 بحسب Nasdaq GlobeNewswire
-
AnaptysBio To Present at the 40th Annual J.P. Morgan Healthcare Conference
05 يناير 2022 16:05:00 بحسب Nasdaq GlobeNewswire
-
AnaptysBio Announces Appointment of Daniel Faga to Board of Directors
29 نوفمبر 2021 16:05:50 بحسب Nasdaq GlobeNewswire